Zhengye Biotechnology Holding Ltd (ZYBT) › EBITDAZhengye Biotechnology Holding Ltd (ZYBT): EBITDAOperating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.-44.62M CNYYear ended 2025-12-3184.63M CNY2022-12-31: 84.63M CNY2023-12-31: 68.90M CNY2024-12-31: 40.60M CNY2025-12-31: -44.62M CNY-44.62M CNY2022-12-31 EBITDA (CNY) 2025-12-31Period endedEBITDAChange YoYSource filing2025-12-31-44.62M CNYn/m2026-04-28, From 2025-01-012024-12-3140.60M CNY-41.1%2026-04-28, From 2024-01-012023-12-3168.90M CNY-18.6%2026-04-28, From 2023-01-012022-12-3184.63M CNYn/a2025-07-03, From 2022-01-01Other metrics: RevenueCost of RevenueGross ProfitR&D ExpenseOperating IncomeDepreciation & AmortizationNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesLong-Term DebtShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowDividends PaidShares OutstandingWeighted Average Diluted SharesEPS (Basic)